September 10, 2019
Synagis (palivizumab) injections

Applicable to: Mercy Care Complete Care, Mercy Care RBHA, Mercy Care Long Term Care and Division of Developmental Disabilities 

Respiratory Syncytial Virus (RSV) season typically begins on November 1st of each year and continues through March of the following year. 

Effective immediately, Synagis (palivizumab) injections to prevent RSV may be provided by any contracted provider for Mercy Care and submitted with CPT Code 90378 - Respiratory syncytial virus, monoclonal antibody, recombinant, for intramuscular use, 50 mg, each.   

Synagis (palivizumab) injections do not require prior authorization.   

As always, don't hesitate to contact your Mercy Care Provider Relations Representative with any questions or comments. You can find this notice and all other provider notices on our Mercy Care website.

We appreciate your continued assistance, support and cooperation!